A witness—who has spent most of his career as a Capitol Hill staffer and drug industry lobbyist—called for “fundamental structural [...] …
Articles by : Luke Zarzecki,
Drugmaker Eli Lilly defended its newly implemented policy requiring covered entities to report 340B claims data for in-house pharmacy utilization [...] …


